X4 Pharmaceuticals (XFOR) has a market capitalization of $69.4M, based on 22.45M shares at a price of $3.09 (down 6.4% on Friday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $3.09 | 3,329,100 | 22,449,131 | $69,367,814.79 |
September 2025 | $3.42 | 10,982,000 | 7,413,000 | $25,352,460.00 |
August 2025 | $3.76 | 212,875,300 | 7,413,000 | $27,835,815.00 |
July 2025 | $1.68 | 38,118,600 | 7,413,000 | $12,453,840.00 |
June 2025 | $1.90 | 8,878,300 | 7,413,000 | $14,084,700.00 |
May 2025 | $3.40 | 3,867,300 | 7,413,000 | $25,204,200.00 |
April 2025 | $4.31 | 2,122,369 | 7,413,000 | $31,950,030.00 |
March 2025 | $7.08 | 1,184,197 | 6,869,100 | $48,633,228.00 |
February 2025 | $11.85 | 1,211,266 | 6,869,100 | $81,398,835.00 |
January 2025 | $21.00 | 4,784,708 | 6,869,100 | $144,251,100.00 |
December 2024 | $22.02 | 2,603,238 | 6,702,000 | $147,578,040.00 |
November 2024 | $11.79 | 3,536,745 | 6,702,000 | $79,016,580.00 |
October 2024 | $15.00 | 1,048,819 | 6,702,000 | $100,530,000.00 |
September 2024 | $20.07 | 479,846 | 6,695,500 | $134,378,685.00 |
August 2024 | $21.00 | 843,252 | 6,695,500 | $140,605,500.00 |
July 2024 | $24.00 | 1,565,889 | 6,695,500 | $160,692,000.00 |
June 2024 | $17.40 | 1,817,877 | 6,693,400 | $116,465,160.00 |
May 2024 | $30.30 | 1,634,613 | 6,693,400 | $202,810,020.00 |
April 2024 | $33.60 | 3,047,216 | 6,693,400 | $224,898,240.00 |
March 2024 | $41.70 | 2,338,155 | 6,666,400 | $277,988,880.00 |
February 2024 | $29.13 | 925,210 | 6,666,400 | $194,192,232.00 |
January 2024 | $23.43 | 837,163 | 6,666,400 | $156,193,752.00 |
December 2023 | $25.17 | 2,409,927 | 6,625,500 | $166,763,835.00 |
November 2023 | $23.40 | 1,438,046 | 6,625,500 | $155,036,700.00 |
October 2023 | $24.03 | 1,028,781 | 6,625,500 | $159,210,765.00 |
